Biosimilar Drugs and the Hospital Formulary: A Canadian Experience

被引：0
|
作者：
Fenna, Jennifer [1 ]
Watkins, Kathy [2 ,3 ]
Guirguis, Micheal [4 ]
机构：
[1] Alberta Hlth Serv, Pharm Serv, Edmonton, AB, Canada
[2] Eastern Reg Hlth Author, Ctr Nursing Studies, St John, NF, Canada
[3] Athabasca Univ, Fac Hlth Disciplines, Edmonton, AB, Canada
[4] Alberta Hlth Serv, Kaye Edmonton Clin, Pharm Serv, Edmonton, AB, Canada
来源：
CANADIAN JOURNAL OF HOSPITAL PHARMACY | 2019年 / 72卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：145 / 150
页数：6
相关论文
共 50 条
  • [41] The Biosimilar Switch: IBD nurse's experience in Our Lady of Lourdes Hospital
    McMahon, S.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I462 - I462
  • [42] HOW DRUGS ATTAIN FORMULARY LISTING
    ROLANDS, TF
    WILLIAMS, RB
    HOSPITALS, 1975, 49 (02): : 87 - 89
  • [43] INCLUSION OF DRUGS IN A FORMULARY: A CASE STUDY
    Jaraki, J.
    Levy, X.
    Palacios, E.
    Zapata, L.
    Aguilar, J. L.
    Marquez, M.
    VALUE IN HEALTH, 2018, 21 : S100 - S100
  • [44] DRUGS ADDED TO GENERIC DRUG FORMULARY
    不详
    WISCONSIN MEDICAL JOURNAL, 1978, 77 (04): : 56 - 56
  • [45] Biosimilar drugs: how safe are they?
    Montoto, Silvia
    LEUKEMIA & LYMPHOMA, 2019, 60 (14) : 3343 - 3344
  • [46] Bills target biosimilar drugs
    Wadman, Meredith
    NATURE, 2009, 458 (7237) : 394 - 395
  • [47] Physician satisfaction with formulary policies: Is it access to formulary or nonformulary drugs that matters most?
    Glassman, PA
    Good, CB
    Kelley, ME
    Bradley, M
    Valentino, M
    AMERICAN JOURNAL OF MANAGED CARE, 2004, 10 (03): : 209 - 216
  • [48] Bills target biosimilar drugs
    Meredith Wadman
    Nature, 2009, 458 : 394 - 395
  • [49] Biosimilar drugs, myths and reality
    Hernandez-Garcia, Cesar
    REUMATOLOGIA CLINICA, 2014, 10 (06): : 351 - 352
  • [50] US biosimilar pathway: New route to biosimilar biologic drugs
    Berks, Andrew
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 242
12345